HLSCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,000 KRW | 0.00% |
|
+0.36% | -12.17% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 52.76B 38.57M | Sales 2023 | 25.59B 18.7M | Capitalization | 81.18B 59.34M |
|---|---|---|---|---|---|
| Net income 2022 | 1.59B 1.16M | Net income 2023 | -1.38B -1.01M | EV / Sales 2022 | 1.29 x |
| Net cash position 2022 | 29.34B 21.44M | Net cash position 2023 | 28.62B 20.92M | EV / Sales 2023 | 2.05 x |
| P/E ratio 2022 |
61.2
x | P/E ratio 2023 |
-59
x | Employees | 76 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.2% |
More Fundamentals
* Assessed data
More news
| 1 week | +0.36% | ||
| Current month | +1.67% | ||
| 1 month | -3.85% | ||
| 3 months | -12.01% | ||
| 6 months | -0.57% | ||
| Current year | -12.17% |
1 week
13 760.00
14 190.00
1 month
13 050.0014 530.00
Current year
13 050.0018 200.00
1 year
11 300.0022 800.00
3 years
11 300.0042 450.00
5 years
11 300.00113 904.76
10 years
11 300.00113 904.76
| Managers | Title | Age | Since |
|---|---|---|---|
Hae-Yeon Lee
CEO | Chief Executive Officer | 55 | 00-09-27 |
Dong-Ryul Lee
BRD | Director/Board Member | 45 | 05-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hae-Yeon Lee
CEO | Chief Executive Officer | 55 | 00-09-27 |
Dong-Ryul Lee
BRD | Director/Board Member | 45 | 05-04-30 |
Dong-Wu Choi
BRD | Director/Board Member | 46 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 14,000 | 0.00% | 2,767 |
| 24-05-09 | 14,000 | +0.21% | 2,697 |
| 24-05-08 | 13,970 | +0.29% | 2,428 |
| 24-05-07 | 13,930 | +0.29% | 1,256 |
| 24-05-03 | 13,890 | -0.43% | 1,166 |
End-of-day quote Korea S.E., May 09, 2024
More quotes
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.
Sector
Food Processing
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.17% | 52.06M | |
| +16.80% | 8.43B | |
| +15.02% | 6.82B | |
| -4.77% | 3.77B | |
| -6.75% | 3.74B | |
| +4.41% | 1.44B | |
| -30.34% | 1.06B | |
| +20.28% | 1.04B | |
| -12.85% | 890M | |
| -15.63% | 812M |
- Stock Market
- Equities
- A239610 Stock